LBT Share Price Value?, page-71

To add to this...

Impedimed (IPD) another US FDA approved medical device which I had traded when it was 27c but did not hold...2 years later it is now $1.50 with a mcap >$500m. I made trading but I would have made a lot more holding it knowing it is truly potential. $1.50 with no revenues!

Another example is Airxpander (AXP) which was recently recommended by a smallcap newsletter with a mcap of $300m is awaiting FDA approval for its breast implant medical device.

LBT is a very rare one to have a mcap of just $70m when it should be in my opinion be at least $100m after FDA approval and will be re-rated as news flow continues. Price at 87c would give a mcap of $100m so those who bought in too high at 95c ought not to panic as I firmly believe LBT would move higher once consolidation completes with weak holders removed.